Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F O Simpson

Showing results (31-40 of 122) with videos related to

Pageof 13
Sort By:
Clinical Science (London, England : 1979)|December 1, 1979
Salt and hypertension: a sceptical review of the evidenceF O Simpson
The Medical Journal of Australia|August 20, 1977
Comment I: some aspects of the pharmacology of prazosin and their clinical implicationsF O Simpson
The New Zealand Medical Journal|July 22, 1987
No evidence that treatment of hypertension does not explain much of the decline in mortality from stroke in New ZealandF O Simpson
Journal of Hypertension|October 1, 1991
Frederick Horace Smirk, KBE, MD, Hon DSc (Hahnemann), FRCP, FRACP: hypertension investigator and pioneer of antihypertensive therapyF O Simpson
Stroke|September 1, 1989
Relationship of treatment for hypertension and stroke mortalityF O Simpson
British Medical Journal|September 23, 1978
HypertensionF O Simpson
Journal of Cardiovascular Pharmacology|January 1, 1984
Salt and hypertension: current data, attitudes, and policiesF O Simpson
Drugs|January 1, 1976
Recent trends in mortality at the Dunedin Hypertension ClinicF O Simpson
Journal of Cardiovascular Pharmacology|January 1, 1990
Fallacies in the interpretation of the large-scale trials of treatment of mild to moderate hypertensionF O Simpson
The New Zealand Medical Journal|May 22, 1974
A preliminary clinical trial of Prazosin: a new oral antihypertensive agentP Bolli, F O Simpson
Pageof 13

Showing results (31-40 of 122) with videos related to

Sort By:
Pageof 13
Clinical Science (London, England : 1979)|December 1, 1979
Salt and hypertension: a sceptical review of the evidenceF O Simpson
The Medical Journal of Australia|August 20, 1977
Comment I: some aspects of the pharmacology of prazosin and their clinical implicationsF O Simpson
The New Zealand Medical Journal|July 22, 1987
No evidence that treatment of hypertension does not explain much of the decline in mortality from stroke in New ZealandF O Simpson
Journal of Hypertension|October 1, 1991
Frederick Horace Smirk, KBE, MD, Hon DSc (Hahnemann), FRCP, FRACP: hypertension investigator and pioneer of antihypertensive therapyF O Simpson
Stroke|September 1, 1989
Relationship of treatment for hypertension and stroke mortalityF O Simpson
British Medical Journal|September 23, 1978
HypertensionF O Simpson
Journal of Cardiovascular Pharmacology|January 1, 1984
Salt and hypertension: current data, attitudes, and policiesF O Simpson
Drugs|January 1, 1976
Recent trends in mortality at the Dunedin Hypertension ClinicF O Simpson
Journal of Cardiovascular Pharmacology|January 1, 1990
Fallacies in the interpretation of the large-scale trials of treatment of mild to moderate hypertensionF O Simpson
The New Zealand Medical Journal|May 22, 1974
A preliminary clinical trial of Prazosin: a new oral antihypertensive agentP Bolli, F O Simpson
Pageof 13